Retinitis Pigmentosa News and Research

RSS
Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.
Retinal dopamine levels rise during inherited retinal degeneration

Retinal dopamine levels rise during inherited retinal degeneration

New photoswitchable drugs restore light perception in blind animals

New photoswitchable drugs restore light perception in blind animals

Transplanted neural progenitor cells survive one year in patients with retinitis pigmentosa

Transplanted neural progenitor cells survive one year in patients with retinitis pigmentosa

Lighting the way towards a new treatment for blindness

Lighting the way towards a new treatment for blindness

Natural molecule erucamide helps slow progressive retinal degeneration

Natural molecule erucamide helps slow progressive retinal degeneration

Photoreceptor cells can recover from early stages of cell death

Photoreceptor cells can recover from early stages of cell death

Ultra-thin nanotechnology enables safe wireless stimulation for retinal degeneration

Ultra-thin nanotechnology enables safe wireless stimulation for retinal degeneration

RNA gene mutations identified as cause of inherited blindness

RNA gene mutations identified as cause of inherited blindness

Non-coding RNA mutations unveiled as new cause of retinitis pigmentosa

Non-coding RNA mutations unveiled as new cause of retinitis pigmentosa

Research breakthrough could provide a new, non-invasive way to assess retinal health

Research breakthrough could provide a new, non-invasive way to assess retinal health

TRPM1 loss drives rhythmic activity across retinal diseases

TRPM1 loss drives rhythmic activity across retinal diseases

New mouse models reveal mechanisms of RP59 retinal degeneration

New mouse models reveal mechanisms of RP59 retinal degeneration

Retinal cells rewire to preserve vision in retinitis pigmentosa

Retinal cells rewire to preserve vision in retinitis pigmentosa

Machine learning unlocks millions of safer CRISPR enzymes for gene editing

Machine learning unlocks millions of safer CRISPR enzymes for gene editing

Gold nanoparticles offer new hope for vision restoration

Gold nanoparticles offer new hope for vision restoration

Reserpine shows promise in treating retinitis pigmentosa in rat studies

Reserpine shows promise in treating retinitis pigmentosa in rat studies

Scientists unveil dynamic structure of protein key to vision

Scientists unveil dynamic structure of protein key to vision

Breakthrough research reveals gut-eye connection in vision loss

Breakthrough research reveals gut-eye connection in vision loss

New drug restores vision by regenerating retinal nerves

New drug restores vision by regenerating retinal nerves

Research provides a comprehensive genomic and epigenomic landscape of ICE syndrome

Research provides a comprehensive genomic and epigenomic landscape of ICE syndrome

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.